Molina Healthcare (NYSE:MOH) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops On Weak Guidance
Molina Healthcare (NYSE:MOH) reported Q2 CY2026 sales of $10.87 billion, down 4.8% year over year and in line with estimates. Full-year revenue guidance was $42 billion at the midpoint, 5.1% below analysts’ expectations. Non-GAAP EPS was $1.51, up 7.8% versus consensus, but the stock fell 6.6% to $207.00 after results.
How this was made
The 30-second read
Why it matters
The market reaction is tied to a full-year revenue guidance midpoint of $42B, which the article says is 5.1% below analysts’ estimates, despite Q2 revenue being in line and EPS beating consensus.
Market read
Traders should focus on the guidance miss versus the EPS beat, as the article attributes a 6.6% immediate stock drop to the results.
What to watch
Customer count declined 3.8% YoY on average over two years, so investors may be underweighting the revenue-per-member dynamic versus pure membership trends.
Background
Molina Healthcare provides managed healthcare services to low-income individuals via Medicaid, Medicare, and Marketplace programs across 21 states.
Ticker impact
Molina Healthcare reported Q2 CY2026 revenue of $10.87B in line, but full-year revenue guidance of $42B midpoint was 5.1% below estimates.
Bearish bias for the next few sessions as investors weigh weaker revenue outlook versus the EPS outperformance.
The article highlights a full-year revenue guidance shortfall versus consensus while noting the stock fell 6.6% to $207 after results, implying the market focused on revenue guidance.
Market effects
Signals pressure on managed-care revenue growth expectations, even as EPS can still beat via cost control or accounting effects.
Limited direct regional spillover; Molina’s Medicaid/Medicare footprint is multi-state.
Primarily US managed-care sentiment, with limited global read-through.
Counterpoint
EPS beat and non-GAAP profit outperformance may indicate costs are being managed well enough to offset some revenue softness.
Key entities
- companyMolina Healthcare
Managed healthcare insurer reporting Q2 CY2026 results and full-year revenue guidance.
- market_referenceWall Street estimates
Analyst consensus used as the benchmark for revenue guidance and EPS expectations.
